Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4473203

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CSCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(C)=O)CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC1=O

Basic Information

ChEMBL ID CHEMBL4473203
Phase Preclinical
Structure Type MOL
InChI Key VDIQLFPDZSQICF-WCAMJISASA-N
3
Targets
13
Activities
2
Assay Types
0
PK Parameters
0
Publications
0
Known Names

Molecular Properties

2911.5
MW (Da)

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C132H192N34O31S5
MW 2911.53

Activity Summary

EC50 9 meas. best 8.49
IC50 4 meas. best 9.47

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Tissue factor pathway inhibitor
CHEMBL3713062
IC50 9.47 8.6875 0.3 4
Tissue factor pathway inhibitor
CHEMBL3713062
EC50 8.49 7.4343 3.2 7
Plasma
CHEMBL613424
EC50 8.4 8.4 4.0 1
Unchecked
CHEMBL612545
EC50 6.77 6.77 170.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Tissue factor pathway inhibitor IC50 = 0.337 nM 9.47 Binding affinity to TFPI (unknown origin) incubated for 1.5 hrs using tracer pep... -
Tissue factor pathway inhibitor IC50 = 0.52 nM 9.28 Binding affinity to TFPI (unknown origin) incubated for 1.5 hrs using 0.5 nM tra... -
Tissue factor pathway inhibitor EC50 = 3.2 nM 8.49 Inhibition of C-terminus 10x-His-taged human TFPI-1 (29 to 282 residues) assesse... -
Plasma EC50 = 4.0 nM 8.4 Improvement in global hemostatic blood coagulation parameters in plasma isolated... -
Tissue factor pathway inhibitor EC50 = 5.9 nM 8.23 Inhibition of fulllength human TFPI-1 assessed as inhibition of factor 10a using... -
Tissue factor pathway inhibitor EC50 = 10.0 nM 8.0 Inhibition of TFPI in human plasma with induced factor-8 deficiency assessed as ... -
Tissue factor pathway inhibitor IC50 = 10.0 nM 8.0 Binding affinity to TFPI (unknown origin) incubated for 1.5 hrs using tracer pep... -
Tissue factor pathway inhibitor IC50 = 10.0 nM 8.0 Binding affinity to TFPI (unknown origin) incubated for 1.5 hrs using tracer pep... -
Tissue factor pathway inhibitor EC50 = 16.0 nM 7.8 Inhibition of TFPI in human plasma with induced factor-9 deficiency assessed as ... -
Unchecked EC50 = 170.0 nM 6.77 Binding affinity to TFPI1-(150 residues) (unknown origin) /thrombin (unknown ori... -
Tissue factor pathway inhibitor EC50 = 170.0 nM 6.77 Binding affinity to TFPI-(160 residues) (unknown origin) -
Tissue factor pathway inhibitor EC50 = 200.0 nM 6.7 Inhibition of C-terminus 10x-His-taged human TFPI-1 (29 to 282 residues) assesse... -
Tissue factor pathway inhibitor EC50 = 900.0 nM 6.05 Inhibition of fulllength human TFPI-1 assessed as suppression of TFPI-mediated i... -

Data from ChEMBL 36 via Core Engine